William Lee
Director/Board Member bei Amygdala Neurosciences, Inc.
Profil
Derzeit ist William A. Lee Executive Vice President-Research bei Gilead Sciences, Inc. Er ist außerdem Mitglied des Vorstands von Molecular Partners AG und Amygdala Neurosciences, Inc. sowie Mitglied von Elevation 6000, LLC. Dr. Lee war zuvor Research Scientist bei Syntex Corp. und Head-Drug Delivery & Formulation bei California Biotechnology, Inc. Er erhielt einen Doktortitel von der University of California San Diego und einen Bachelor-Abschluss von der University of Massachusetts.
Aktive Positionen von William Lee
| Unternehmen | Position | Beginn |
|---|---|---|
Elevation 6000, LLC
 Elevation 6000, LLC Real Estate DevelopmentFinance Elevation 6000, LLC provides real estate brokerage services. | Corporate Officer/Principal | - |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von William Lee
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 12.04.2021 |
| MOLECULAR PARTNERS AG | Director/Board Member | 29.04.2020 |
| California Biotechnology, Inc. | Corporate Officer/Principal | 01.01.1991 |
| Syntex Corp. | Corporate Officer/Principal | - |
Ausbildung von William Lee
| University of California San Diego | Doctorate Degree |
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Syntex Corp. | Health Technology |
| California Biotechnology, Inc. | Health Technology |
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Health Technology |
Elevation 6000, LLC
Elevation 6000, LLC Real Estate DevelopmentFinance Elevation 6000, LLC provides real estate brokerage services. | Finance |
